StemCell.Directory
Menu
  • Home
  • Blog
  • Connect
  • FAQ
  • Submit Event
  • Submit Listing
StemCell.Directory
Menu
  • Home
  • Blog
  • Connect
  • FAQ
  • Submit Event
  • Submit Listing

Stem cells hold promise in treating retinal degeneration

Published by GP On May 25, 2009

From Louisville.edu

A team of University of Louisville scientists have discovered that stem cells taken from bone marrow can restore damaged retinal tissue by generating new cells. This is the first known study where stem cells derived from bone marrow have been used to restore the pigmented cell layer just outside the retina or the retinal pigment epithelium (RPE).

The research moves science a step closer to helping those who suffer from vision loss and blindness due to age-related macular degeneration and hereditary retinal degenerations.

During their experiments, UofL researchers found that bone-marrow derived stem cells (BMSCs) were attracted to damaged RPE, and were able to differentiate or move from less specialized cells into components of RPE.

According to researcher Suzanne Ildstad, “More research is needed to optimize the outcome and potential for repair of damaged retinal pigment epithelium. A combination with up-to-date tissue engineering might be critical for ultimate success.”

UofL Department of Ophthalmology and Visual Sciences researcher Henry Kaplan is now expanding this research in conjunction with the Swine Institute at the University of Missouri. Kaplan says pigs have more optical similarities to humans.

“After learning more about how bone-marrow derived stem cells can help regenerate retinal pigment epithelium in swine, we hope to translate our research into the clinical setting,” Kaplan said.

This research has implications for a number of chronic diseases including congestive heart failure, diabetes, osteoporosis, Alzheimer and Parkinson diseases, spinal cord injuries, age-related macular degeneration and hereditary retinal degenerations.

Age-related macular degeneration affects 10 percent to 20 percent of people over the age of 65 years old. Hereditary retinal degeneration is another leading cause of blindness and typically involves an onset of night blindness, an early loss of peripheral vision and late loss of central vision.

The study, published recently in the Archives of Ophthalmology, is available online at archopht.ama-assn.org/cgi/content/short/127/4/563.

  • Share
Categories: News Tags: bone-marrow, retinal, RPE, stem cells
← PreviousNext →

Subscribe To Our Newsletter

Subscribe to get latest news from site

Submit Your Listing

Get maximum online exposure for your business by submitting a listing on our directory. Benefit from our audience of visitors who seek the services and products you're promoting. Click here, Submit Listing.

Marketplace

“Adspace

About StemCell.Directory

StemCell.Directory is a Fully Searchable, Human-edited Directory for the entire Stem Cell Industry. We invite all Doctors, Researchers, Corporations, and Associations to join our ever-growing community. Start here

Tags

video UCLA teeth stem cells skin cells reprogramming pluripotent NIH MS mesenchymal liver leukemia ISCO iPSC iPS heart embryonic diabetes cornea cord-blood CIRM cancer bone-marrow ALS

DISCLAIMER

StemCell.Directory disclaims any liability, loss, or risk, directly or indirectly of the application of any of the contents found on this web site. Always consult a medical professional regarding treatment.

© 2023 Stem Cell Directory | Built by Brainguzzle

Sign In

Forgot your password?

Forgot password

Inquiry for
Stem cells hold promise in treating retinal degeneration

x